Acadian Asset Management
TAK icon

Acadian Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Acadian Asset Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Sell
797
-6,876
-90% -$114K ﹤0.01% 1945
2026
Q1 		$142K Sell
7,673
-20,668
-73% -$363K ﹤0.01% 1674
2025
Q4 		$441K Buy
+28,341
New +$405K ﹤0.01% 1338

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Acadian Asset Management's TAK Position: Q2 2026 in Review

Acadian Asset Management reduced its Takeda Pharmaceutical (TAK) stake by 90% in Q2 2026, selling an estimated $114K and leaving 797 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1945.

Acadian Asset Management first reported a position in TAK in Q4 2025 and has held it in 3 quarters since. The position peaked at $441K in Q4 2025. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Acadian Asset Management held 797 shares of Takeda Pharmaceutical worth $12K as of Q2 2026.
  • Acadian Asset Management sold 6,876 Takeda Pharmaceutical shares in Q2 2026, an estimated $114K.
  • Takeda Pharmaceutical made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1945 holding.
  • Acadian Asset Management first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • Acadian Asset Management's Takeda Pharmaceutical position peaked at $441K in Q4 2025.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.